Clinical impact of anti retroviral resistance testing : current problems and future directionsRUSCONI, Stefano; MORONI, Mauro.International journal of antimicrobial agents. 2000, Vol 16, Num 4, pp 425-427, issn 0924-8579Conference Paper

HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy eraMORONI, Mauro; ANTINORI, Spinello.AIDS (Supplement). 2003, Vol 17, pp S51-S64, issn 1350-2840, SUP1Article

Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detectionRIZZO, Vittoria; PORTA, Camillo; MORONI, Mauro et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 774, Num 1, pp 17-24, issn 1387-2273Article

Salivary stone lithotripsy in the HIV patientCAPACCIO, Pasquale; D'ARMINIO MONFORTE, Antonella; MORONI, Mauro et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2002, Vol 93, Num 5, pp 525-527, issn 1079-2104Article

Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring studySARTORE-BIANCHI, Andrea; FIEUWS, Stiffen; SKOKAN, Margaret et al.Journal of clinical pathology. 2012, Vol 65, Num 3, pp 220-225, issn 0021-9746, 6 p.Article

Cell therapy of stage IV nasopharyngeal carcinoma with autologous epstein-barr virus-targeted cytotoxic T lymphocytesCOMOLI, Patrizia; PEDRAZZOLI, Paolo; MORONI, Mauro et al.Journal of clinical oncology. 2005, Vol 23, Num 35, pp 8942-8949, issn 0732-183X, 8 p.Article

Pneumocystis carinii pneumonia after the discontinuation of long-term antiretroviral therapy in an HIV-1-infected pregnant womanGERVASONI, Cristina; VACCAREZZA, Mauro; RIDOLFO, Anna Lisa et al.AIDS (London). 2003, Vol 17, Num 6, pp 940-941, issn 0269-9370, 2 p.Article

The Pavia consensus statementVOLBERDING, Paul A; MURPHY, Robert L; GALLI, Massimo et al.AIDS (Supplement). 2003, Vol 17, pp S170-S179, issn 1350-2840, SUP1Article

Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients : Evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trialJOLY, Véronique; MORONI, Mauro; WILKINS, Edmund G. L et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 11, pp 3155-3157, issn 0066-4804Article

IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patientsMARCHETTI, Giulia; MERONI, Luca; MOLTENI, Chiara et al.Antiviral therapy (London). 2004, Vol 9, Num 3, pp 447-452, issn 1359-6535, 6 p.Article

Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamicsMARCHETTI, Giulia; MERONI, Luca; MOLTENI, Chiara et al.AIDS (London). 2004, Vol 18, Num 2, pp 211-216, issn 0269-9370, 6 p.Article

Increased risk of developing peripheral neuropathy in patients coinfected with HIV-1 and HTLV-2ZEHENDER, Gianguglielmo; COLASANTE, Chiara; MORONI, Mauro et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 4, pp 440-447, issn 1525-4135, 8 p.Article

Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapyCORBELLINO, Mario; BESTETTI, Giovanna; PARRAVICINI, Carlo et al.Blood. 2001, Vol 98, Num 12, pp 3473-3475, issn 0006-4971Article

Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infectionREZZA, Giovanni; LEPRI, Alessandro Cozzi; MANCONI, Paolo Emilio et al.Journal of acquired immune deficiency syndromes (1999). 2000, Vol 25, Num 1, pp 56-62, issn 1525-4135Article

Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot phase I/II trialGORI, Andrea; TRABATTONI, Daria; GALLI, Massimo et al.Antiviral therapy (London). 2004, Vol 9, Num 4, pp 603-614, issn 1359-6535, 12 p.Article

Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian cohort naive antiretrovirals (I.Co.N.A.) studyCOZZI-LEPRI, Alessandro; PHILLIPS, Andrew N; MORONI, Mauro et al.The Journal of infectious diseases. 2002, Vol 185, Num 8, pp 1062-1069, issn 0022-1899Article

When to start highly active antiretroviral therapy in chronically HIV-infected patients : evidence from the ICONA studyCOZZI LEPRI, Alessandro; PHILLIPS, Andrew N; PISCOPO, Rita et al.AIDS (London). 2001, Vol 15, Num 8, pp 983-990, issn 0269-9370Article

Virological response in multidrug-experienced hiv-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosineRUSCONI, Stefano; LA SETA CATAMANCIO, Simona; CITTERIO, Paola et al.Antiviral therapy (London). 2001, Vol 6, Num 1, pp 41-46, issn 1359-6535Conference Paper

Controversial evaluation of EGFR protein and gene status in predicting response to anti-EGFR monoclonal antibodies in metastatic colorectal cancer : a case report and review of the literatureMORONI, Mauro; VERONESE, Silvio; SARTORE-BIANCHI, Andrea et al.Targeted oncology. 2008, Vol 3, Num 2, pp 127-130, issn 1776-2596, 4 p.Article

Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirinMILAZZO, Laura; BIASIN, Mara; GATTI, Nadia et al.The American journal of gastroenterology. 2006, Vol 101, Num 2, pp 399-402, issn 0002-9270, 4 p.Article

[¹³C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicityMILAZZO, Laura; PIAZZA, Manuela; SANGALETTI, Ornella et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 1, pp 84-89, issn 0305-7453, 6 p.Article

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapyVIOLIN, Michela; COZZI-LEPRI, Alessandro; MORONI, Mauro et al.AIDS (London). 2004, Vol 18, Num 2, pp 227-235, issn 0269-9370, 9 p.Article

Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapyGALLI, Massimo; RIDOLFO, Anna Lisa; MORONI, Mauro et al.Antiviral therapy (London). 2003, Vol 8, Num 4, pp 347-354, issn 1359-6535, 8 p.Article

Low-dose prolonged intermittent interleukin-2 adjuvant therapy: Results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairmentMARCHETTI, Giulia; MERONI, Luca; GALLI, Massimo et al.The Journal of infectious diseases. 2002, Vol 186, Num 5, pp 606-616, issn 0022-1899, 11 p.Article

Self-reported symptoms and medication side effects influence Adherence to highly active antiretroviral therapy in persons with HIV infectionAMMASSARI, Adriana; MURRI, Rita; NAPPA, Salvatore et al.Journal of acquired immune deficiency syndromes (1999). 2001, Vol 28, Num 5, pp 445-449, issn 1525-4135Article